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Ten years ago, it was hypothesized that expo-
sure of the developing male fetus to environ-
mental estrogens may be responsible for
anomalies of sexual maturation and reproduc-
tive function in adult life (Anonymous 1995).
Male sexual differentiation and reproductive
functioning are critically dependent on a bal-
anced androgen:estrogen ratio. In this regard,
two common male reproductive-tract malfor-
mations—cryptorchidism (failure of one or
both testicles to descend into scrotum) and
hypospadias (urethral opening on ventral side
of penis)—are birth defects of prenatal origin
that may be related to in utero exposure to
estrogens/androgens. 
Animal (Edwards et al. 2006) and human
data (Nurminen 2001) point toward a causal
relationship between exposure to pesticides
during pregnancy and the development of
congenital malformations. In fact, parental
involvement in agricultural work and/or
parental exposure to pesticides has been associ-
ated with higher risk of a wide range of con-
genital malformations (Kristensen et al. 1997).
For example, in Spain, maternal involvement
in agricultural activity during the month
before conception and the first trimester of
pregnancy was followed by a 3-fold increase in
the risk of bearing a child with a malformation
(Garcia et al. 1999). Moreover, an ecologic
investigation into variations in orchidopexy
rates in the Spanish province of Granada
found an association between exposure to pes-
ticides and the risk of cryptorchidism (García-
Rodriguez et al. 1996). A later retrospective
case–control study in the same geographic area
suggested that cryptorchidism was related to
the father’s employment in agriculture (Rueda-
Domingo et al. 2001).
Because of their persistence in the environ-
ment, pesticides are common contaminants in
soil, water, and wildlife and are present in tis-
sues of mothers and children, especially in
regions devoted to intensive agriculture
(Botella et al. 2004; Cerrillo et al. 2006; Olea
et al. 1999). Their ubiquity supports the plau-
sibility of embryo-fetal exposure during preg-
nancy, although mutagenic or epigenetic
parental germ cell damage cannot be ruled out.
Some organochlorine pesticides are endocrine
disrupting chemicals (EDCs) (Soto et al.
1995), defined as exogenous substances or
mixtures with the ability to disrupt hormonal
homeostasis, alter endocrine system functions,
and consequently cause adverse health effects
in an intact organism or its progeny or sub-
populations. EDC pesticides are now consid-
ered to include not only chemicals with
estrogenic and androgenic properties but also
those with antihormonal and enzymatic/meta-
bolic properties (Almstrup et al. 2002).
Maternal exposure to pesticides has been
associated with urogenital malformations,
semen quality impairment, and testicular,
prostate, ovarian, and breast cancer (Koifman
et al. 2002). Thus, an excess of cryptorchidism
but not of hypospadias was reported in sons of
women working in farming, especially horti-
culture (Weidner et al. 1998), whereas the
occupation of the father had no inﬂuence on
the risk of either cryptorchidism or hypospa-
dias. Kristensen and coworkers (1997), who
studied the association of different birth
defects with farm purchases of pesticides and
tractor pesticide spraying equipment, found a
positive relationship with cryptorchidism and a
moderate association with hypospadias.
However, when exposure assessment was based
on parental occupation (farmers vs. other
jobs), no signiﬁcant differences were observed.
Occupational exposure of the father was asso-
ciated with cryptorchidism in a nested
case–control study conducted by Pierik et al.
(2004), and with hypospadias in an investiga-
tion by Irgens et al. (2000). In contrast with
the above studies, other authors found no asso-
ciation between cryptorchidism and maternal
exposure to pesticides during pregnancy
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BACKGROUND: Exposure to xenoestrogens during pregnancy may disturb the development and
function of male sexual organs. 
OBJECTIVE: In this study we aimed to determine whether the combined effect of environmental
estrogens measured as total effective xenoestrogen burden (TEXB) is a risk factor for male uro-
genital malformations. 
METHODS: In a case–control study, nested in a mother–child cohort (n = 702) established at
Granada University Hospital, we compared 50 newborns with diagnosis of cryptorchidism and/or
hypospadias with 114 boys without malformations matched by gestational age, date of birth, and
parity. Controls did not differ from the total cohort in confounding variables. TEXB and levels of
16 organochlorine pesticides were measured in placenta tissues. Characteristics of parents, preg-
nancy, and birth were gathered by questionnaire. We used conditional and unconditional regres-
sion models to estimate odds ratios (ORs) and 95% conﬁdence intervals (CIs). 
RESULTS: TEXB from organohalogenated compounds was detectable in 72% and 54% of case and
control placentas, respectively. Compared with controls, cases had an OR for detectable versus non-
detectable TEXB of 2.82 (95% CI, 1.10–7.24). More pesticides were detected in cases than in con-
trols (9.34 ± 3.19 vs. 6.97 ± 3.93). ORs for cases with detectable levels of pesticides, after adjusting
for potential confounders in the conditional regression analysis, were o,p´-DDT (OR = 2.25; 95%
CI, 1.03–4.89), p,p´-DDT (OR = 2.63; 95% CI, 1.21–5.72), lindane (OR = 3.38; 95% CI,
1.36–8.38), mirex (OR = 2.85; 95% CI, 1.22–6.66), and endosulfan alpha (OR = 2.19; 95% CI,
0.99–4.82). Engagement of mothers in agriculture (OR = 3.47; 95% CI, 1.33–9.03), fathers’ occu-
pational exposure to xenoestrogens (OR = 2.98; 95% CI, 1.11–8.01), and history of previous still-
births (OR = 4.20; 95% CI, 1.11–16.66) were also associated with risk of malformations. 
CONCLUSIONS: We found an increased risk for male urogenital malformations related to the com-
bined effect of environmental estrogens in placenta.
KEY WORDS: cryptorchidism, endocrine-disrupting chemicals, environmental estrogens, hypo-
spadias, occupational exposure, risk factors. Environ Health Perspect 115(suppl 1):8–14 (2007).
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and occupational exposure to EDCs by the
mother (Aho et al. 2000; Vrijheid et al. 2003),
or between serum levels of dichlorodiphenyl-
dichloroethene (DDE) in the third trimester
of pregnancy and risk of malformations
(Longnecker et al. 2002). These inconsistent
results led to the conclusion that epidemio-
logic studies do not provide sufficient
grounds to support a role for environmental
estrogens in urogenital malformations, and
that a more focused exposure assessment
methodology is required, with more specific
markers of embryo-fetal exposure (Dolk and
Vrijheid 2003; Silva et al. 2002; Vidaeff and
Sever 2005). 
The need for data to support the endocrine
disruptor hypothesis prompted the European
Community to support a prospective multi-
center cohort study in ﬁve European countries
(Denmark, England, Finland, France, and
Spain) to explore the possible association
between exposure of the male fetus to
endocrine disruptors and sex differentiation
disorders. A prospective mother–child cohort
was established in Granada (southern Spain),
in which a case–control study was nested for
investigation of the main risk factors for male
urogenital malformations. In the present study,
we examined the relationship between cryp-
torchidism or hypospadias and environmental
factors, with special emphasis on exposure to
xenoestrogens, estimated by assessment of the
combined estrogenic effects of chemicals
extracted from placentas.
Methods
Design and participants. From October 2000
to July 2002, we recruited male newborns reg-
istered at the San Cecilio University Hospital
(one of the two reference public hospitals serv-
ing Granada province in southern Spain),
excluding delivering mothers with serious
chronic diseases, such as diabetes, hyperten-
sion, or thyroid disease, those who developed
any pregnancy complication that could affect
fetal growth or development, and nonresidents
in the hospital referral area. A total cohort of
702 mother–son pairs was established. All boys
with urogenital malformations (cryptorchidism
and/or hypospadias) born in the study period
were included. This study was approved by the
Institutional Ethical Committee of the San
Cecilio University Hospital, and all participat-
ing mothers signed informed consent.
All mothers were of Caucasian origin. All
boys in the cohort were examined at birth
(within 2 days), and those diagnosed with
cryptorchidism and/or hypospadias were reex-
amined at 1 month of age. Only boys with
congenital malformations at reexamination
were considered cases. The examination tech-
nique and definition of cryptorchidism and
hypospadias followed recommendations of a
Danish–Finnish study (Boisen et al. 2004)
developed by Scorer (1964). In brief, all exam-
inations were done by two physicians in warm
conditions (room temperature 20–24°C) with
the child in supine position. Testicular posi-
tion was recorded after manipulation of the
testis to the most distal position along the
pathway of normal descent using firm trac-
tion. Fifty boys were diagnosed with cryp-
torchidism and/or hypospadias; two of these
were excluded from the investigation because
their parents refused to participate. For each
case, three controls were selected by gesta-
tional age (± 1 week), date of birth (± 7 days),
and parity (primiparous/multiparous).
Although the case–control ratio was 1:3, only
114 controls met the matching criteria. Cases
were 27 boys born with undescended testes
(19 unilaterally, 8 bilaterally) that persisted
until 30 days of age, 19 boys born with
hypospadias, and 2 boys born with both mal-
formations. Among cryptorchidism, 17 were
severe and 12 were mild cases, classifying non-
palpable inguinal and/or suprascrotal cases as
severe and high scrotal cases as mild. 
Information on potential confounding
variables related to parents, pregnancy and
delivery, and activities with potential for pes-
ticide exposure were gathered from structured
face-to-face interviews with the mother held
within the first 48 hr after delivery. Both
mother and interviewer were blinded to the
case or control status of the child.
Occupational exposure was derived from
questions on paid employment and jobs
focusing on chemicals with possible endocrine
activity or previously described as male repro-
ductive toxicants (van Tongeren et al. 2002).
Questionnaires were completed for 47 (96%)
cases and 105 (92%) controls. 
Preliminary statistical analysis demon-
strated similar characteristics between boys in
the mother–child cohort and those selected as
controls in the case–control study, except for a
small difference in father’s age (cohort, 33.6 ±
5.7 years vs. controls, 31.8 ± 5.3 years; p =
0.01) and in gestational age in days (cohort,
276.6 ± 9.2 days vs. controls, 272.6 ± 11.6
days; p = 0.002), although not when expressed
in weeks (39.5 ± 1.3 weeks vs. 38.9 ± 1.6
weeks, p = 0.9).
Laboratory analyses. Samples of placenta
without deciduas basalis and chorionic plate
were collected at the time of delivery from 36
(75%) cases and 109 (95.6%) controls and
sent to the Laboratory of Medical Investigation
for analysis. They were immediately frozen at
–70°C and stored. Before analysis, the placenta
was defrosted and mechanically homogenized.
The laboratory was blinded to the case–control
status of samples. Bioaccumulated compounds
were extracted from samples by a previously
described method (Fernandez et al. 2004) with
slight modifications. Briefly, 1.6 g placenta
homogenate were dissolved in hexane and
eluted in a glass column ﬁlled with Alumine
Merck 90 (70–230 mesh no. 1097; Merck,
Darmstadt, Germany) that had been dried at
600°C for 4 hr, followed by the addition of
5% water. The eluate obtained was concen-
trated at reduced pressure under nitrogen
stream to a volume of 800 µL and then
injected (4 × 200 µL) into the preparative
high-pressure liquid chromatography (HPLC)
(Waters model 501 Millipore apparatus with
ultraviolet/visible detector model 490;
Millipore, Marlborough, MA, USA). One
microliter of HPLC chromatography fraction
was dried, dissolved in n-hexane, and then
injected into a gas chromatography apparatus.
The presence of aldrin, dieldrin, endrin,
lindane, methoxychlor, endosulphan I and
II, mirex, o,p´-DDT (dichlorodiphenyl-
trichloroethane), p,p´-DDT, o,p´-DDD
(dichlorodiphenyldichloroethane), p,p´-DDE,
endosulfan diol, sulfate, lactone, and ether was
determined by gas chromatography with
electron-capture detection, using p´-dichloro-
benzophenone as internal standard, and mass
spectrometry. Standard solutions of organo-
chlorine compounds were analyzed previously
to determine retention times and calibration
curves of these chemicals. The calibration lin-
earity of all chemicals in pure and processed
standards was > 0.98. The recovery of studied
chemicals, measured by spiking placenta sam-
ples with pure chemicals, ranged from 84 to
102%. The operational quality control and
limits of detection and quantification were
previously reported (Lopez-Espinosa et al.
2006; Moreno-Frias et al. 2001). The limit of
detection (LOD) ranged from 0.1 to 3 ng/mL.
The reproducibility of the process was estab-
lished by running 10 placenta samples 10
times. The gas chromatography apparatus
(Varian-3350; Varian Inc., Walnut Creek,
CA, USA) with Millennium Chromatography
Manager software was equipped with a methyl
silicone column (length 30 m) and dual Ni-63
electron capture detectors. The gas chro-
matography-mass spectrometry apparatus
(Saturn 2000; Varian Inc.) with automatic
injector was equipped with a DB5-MS capil-
lary column (30 m × 0.25 mm). Results are
presented with recovery correction.
We estimated the total effective xenoestro-
gen burden (TEXB) to measure the exposure
to xenoestrogens in placenta extracts.
Previously, an HPLC method was developed
to separate natural estrogens (β fraction) from
more lipophilic xenoestrogens (α fraction)
without destroying either (Fernandez et al.
2004; Soto et al. 1997). Extensive testing
demonstrated that the pesticides DDT and
metabolites and dieldrin, aldrin, and lindane,
among other organochlorines, all elute in the
HPLC α-fraction, along with other chlori-
nated and/or brominated organohalogenated
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which contains no endogenous sex-hormones,
can be considered a marker of the TEXB of
environmental organohalogenated estrogens
(Ibarluzea et al. 2004). The combined estro-
genic effect is analyzed from its proliferative
effect on MCF-7 human breast cancer cells
and expressed as estradiol equivalent units.
Duplicated dry pooled α and β fractions
(eluted from 0 to 11 min and from 13 to
30 min, respectively) were resuspended in
charcoal-dextran serum and tested in the
E-SCREEN bioassay for estrogenicity using a
slight modiﬁcation of the originally described
technique (Soto et al. 1995). Each sample was
assayed in triplicate with a negative (vehicle)
and positive (estradiol) control in each plate.
The proliferative effect of the fractions was
referred to the maximal effect obtained with
estradiol transformed into estradiol equivalent
units (Eeq), by reading from a dose–response
curve prepared using estradiol (concentration
range 0.1 pM to 10 nM), and was expressed as
total effective xenoestrogen burden (TEXB-α
and TEXB-β) in Eeq per gram of tissue and
per gram of lipid (Ibarluzea et al. 2004).
Statistical analysis. We performed statisti-
cal analysis to determine associations between
predictors of interest and the presence of cryp-
torchidism and/or hypospadias and between
exposure to environmental pesticides and
these urogenital malformations. Descriptive
statistics are reported as arithmetic mean ±
SD. All statistical analyses were performed
using SPSS statistical software for Windows
version 11.0 (SPSS Inc., Chicago, IL, USA).
We computed odds ratios (ORs) for malfor-
mation and 95% conﬁdence interval (CI) by
unconditional and conditional logistic regres-
sion. We adjusted for potential confounders
and matching variables. Potential confound-
ing variables were selected on the basis of their
significant association with outcomes in the
univariate models. In addition, exposure vari-
ables of interest from the literature were
included. The modifying effect of these vari-
ables and their association with organochlo-
rine levels and TEXB values were investigated.
In the ﬁnal adjusted model, only maternal age
and newborn birth weight had substantial
effect on results. We also tested interactions of
all variables for significance. Differences
between groups were tested with Pearson´s
chi-square test or Fisher´s exact test, when
appropriate. Pesticide levels and TEXB were
also analyzed using an analysis of variance test.
Results
There was a 1.8% prevalence of cryptorchidism
plus hypospadias in our cohort. Considered
separately, the prevalence of cryptorchidism at
1 month of age was 1.1%, and the prevalence
of hypospadias at delivery was 0.74%. 
Mean age (± SD) of the mothers was 29 ±
4.96 years, 9.2% of the mothers were illiterate,
and 14.5% had university studies. More than
half of the women lived in rural areas (53.9%),
but only 13.2% stated work in agriculture.
One of four of the women were overweight or
obese before pregnancy, according to World
Health Organization criteria (World Health
Organization 1998) [body mass index (BMI)
> 25]. Table 1 shows the relationships between
selected characteristics and urogenital malfor-
mations. After testing a large number of more
complex stratiﬁcations, we categorized mater-
nal occupation as agricultural or other. An
almost 3.5-fold increase in risk for urogenital
Fernandez et al.
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Table 1. Selected characteristics of parents, pregnancy, delivery, and infants in relation to urogenital malformations according to case/control status of newborn.
aUnadjusted; an OR of 1 denotes the reference category. bUrban, > 10,000 inhabitants; rural, ≤ 10,000 inhabitants. cWe derived occupational exposure from generic questions on paid
employment and jobs focusing on chemicals that may have endocrine activity or that have previously been described as male reproductive toxicants (van Tongeren et al. 2002).
dMother’s age, father´s age, BMI [weight (kg)/height (m)2], pregnancy weight gain (kg), length, and head circumference at birth were categorized below and above the median value of
the case–control study. eEpispadia, phymosis, hydrocele, and/or micropenis.
Cases Controls 
Variable [n (%)] [n (%)] p-Value ORa (95% CI)
Place of residenceb
Urban 9 (29.0) 22 (71.0) 0.75 1
Rural 39 (32.0) 87 (68.0) 0.91 (0.48–2.72)
Mother´s occupation 
Other 37 (26.1) 105 (73.9) 0.01 1
Agriculture 11 (55.0) 9 (47.9) 3.47 (1.33–9.03)
Father’s occupation exposurec
Low 7 (20.6) 27 (79.4) 0.03 1
Medium 15 (25.4) 44 (74.6) 0.76 (0.47–3.64)
High 24 (43.6) 31 (56.4) 2.98 (1.11–8.01)
Mother’s age (years)d
≤ 30 33 (37.1) 56 (62.9) 0.09 1
> 30 15 (24.2) 47 (75.8) 0.54 (0.26–1.06)
Father´s age (years)d
≤ 31 29 (35.8) 52 (64.2) 0.18 1
> 31 18 (25.7) 52 (74.3) 1.61 (0.79–3.25)
BMI before pregnancyd
≤ 23 19 (25.3) 56 (74.7) 0.11 1
> 23 28 (37.3) 47 (62.7) 1.57 (0.28–1.14)
Previous pregnancy
Yes 18 (29.5) 43 (70.5) 0.75 1
No 29 (31.9) 62 (68.1) 1.12 (0.56–2.26)
Previous stillbirths
No 31 (26.3) 87 (73.7) 0.02 1
Yes 6 (60.0) 4 (40.0) 4.20 (1.11–16.66)
Problems during pregnancy
No 23 (30.3) 53 (69.7) 0.83 1
Yes 19 (28.8) 47 (71.2) 0.98 (0.46–1.89)
Hyperemesis gravidarium
No 19 (27.9) 49 (72.1) 0.64 1
Yes 23 (31.1) 51 (68.9) 1.22 (0.58–2.59)
Bleeding during pregnancy
No 7 (35.0) 13 (65.0) 0.97 1
Yes 35 (28.7) 87 (71.3) 1.21 (0.54–2.70)
Cases Controls 
Variable [n (%)] [n (%)] p-Value ORa (95% CI)
Pregnancy weight gain (kg)d
< 12 26 (36.6) 45 (63.4) 0.07 1
≥ 12 16 (22.9) 54 (77.1) 0.56 (0.26–1.06)
Oral contraceptive before pregnancy 
No 31 (32.6) 64 (67.4) 0.56 1
Yes 16 (28.1) 41 (71.9) 0.81 (0.36–1.65)
Prenatal smoking
Nonsmoker 36 (34.0) 70 (66.0) 0.22 1
Smoker 11 (23.9) 35 (76.1) 0.61 (0.28–1.34)
Method of delivery 
Spontaneous 22 (25.9) 63 (74.1) 0.14 1
Instrumental 2 (12.5) 14 (87.5) 0.51 (0.20–1.26)
Cesarean 11 (40.7) 16 (59.3) 2.44 (0.51–11.62)
Fetal presentation
Normal (cephalic) 32 (27.8) 83 (72.2) 0.88 1
Abnormal (breech/transverse) 3 (30.0) 7 (70.0) 0.90 (0.22–3.69)
Gestational age (weeks)
≥ 37 35 (26.7) 96 (73.3) 0.10 1
< 37 13 (41.9) 18 (58.1) 1.98 (0.88–4.46)
Birth weight (g)
≥ 2,500 43 (28.3) 109 (71.7) 0.14 1
< 2,500 5 (50.0) 5 (50.0) 2.54 (0.69–9.17)
Season of birth
Spring 11 (23.4) 36 (76.6) 1
Summer 6 (23.1) 20 (76.9) 0.08 1.12 (0.00–8.08)
Autumn 12 (30.8) 27 (69.2) 1.11 (0.98–3.41)
Winter 14 (35.0) 26 (65.0) 1.28 (1.19–9.12)
Length at birth (cm)d
< 50.9 28 (41.8) 39 (58.2) 0.04 1
≥ 50.9 15 (25.0) 45 (75.0) 0.46 (0.22–0.99)
Head circumference (cm)d
≤ 34.6 26 (36.1) 46 (63.9) 0.54 1
> 34.6 17 (30.9) 38 (69.1) 1.26 (0.59–2.66)
Minor incidencese
No 21 (43.8) 46 (29.8) 0.08 1
Yes 27 (56.3) 38 (70.2) 1.83 (0.95–3.67)malformation was observed when the mother
reported taking part in agricultural activities.
In contrast, when the father’s work was cate-
gorized as agricultural or other, no association
was found. However, when a different
approach was taken and fathers were asked
about speciﬁc work tasks and chemical expo-
sures, a 2.98-fold increased risk of urogenital
malformation was found for the highest ver-
sus lowest occupational exposure level. Effects
of an urban or rural setting on mother–child
exposure were examined by categorizing their
place of residence as having a population of
more (urban) or less (rural) than 10,000
inhabitants, but no association was found.
A history of spontaneous abortion was
associated with an increased risk of cryp-
torchidism and/or hypospadias (OR= 4.20;
95% CI, 1.11–16.66). Other maternal charac-
teristics that were studied but showed no asso-
ciation with cryptorchidism or hypospadias
were problems during pregnancy (i.e., hyper-
emesis, episodes of bleeding, and loss of amni-
otic fluid), use of oral contraceptive before
pregnancy, and smoking habit (Table 1). No
association was seen with maternal weight,
although when BMI was categorized below
and above the mean value of the study popula-
tion (23 kg/m2), a higher BMI was borderline
significantly associated with risk of cryp-
torchidism and/or hypospadias in the condi-
tional regression analysis adjusted for maternal
age and birth weight [adjusted OR (AOR) =
1.89; 95% CI, 0.84–4.26]. 
A weight gain of ≥ 12 kg during pregnancy
appeared to have a protective effect (OR =
0.56; 95% CI, 0.26–1.06). Interestingly,
mothers of cases gained signiﬁcantly (p = 0.07)
less weight during pregnancy (11.3 ± 4.7 kg)
compared with mothers of controls (13.9 ±
5.5 kg) (Table 1).
Effects on risk of urogenital anomaly of
type of delivery, fetal presentation, weeks of
gestation, child weight and length, head size,
presence of other malformation, and season of
birth are also shown in Table 1. The risk
increased with decreasing birth length (p <
0.05) but not with decreasing birth weight
(OR = 2.54; 95% CI, 0.69–9.17), although
the latter was close to statistical significance
(p = 0.1). Interestingly, the mean weight of
cases (3110.63 ± 614.67 g) was significantly
(p = 0.03) lower than the mean weight of
controls (3304.39 ± 449.13 g). 
Weeks of gestation, with category bound-
ary established at 37 weeks, was associated
with risk of malformation, with a more fre-
quent presence of cryptorchidism and/or
hypospadias in the group of lower gestational
age (OR = 1.98; 95% CI, 0.88–4.46), and
this risk was higher in the conditional logistic
analysis [crude OR (COR) = 4.18; 95% CI,
0.75–23.34; AOR = 2.29; 95% CI,
0.38–13.74]. Delivery by cesarean was more
frequent in the cryptorchidism/hypospadias
group (OR = 2.44; 95% CI, 0.51–11.62). 
The season of birth had an effect in our
study population. Taking spring as category
reference, more boys with malformations
were born in another season, especially in
winter (COR = 1.28; 95% CI, 1.19–9.12),
although without statistical signiﬁcance in the
conditional logistic analysis adjusted for
maternal age and birth weight (AOR = 5.42;
95% CI, 0.56–15.42). Finally, the risk of
cryptorchidism and/or hypospadias was asso-
ciated with presence of minor disorders of the
urogenital tract such as phymosis, hydrocele,
epispadia, and/or micropenis (OR = 1.83;
95% CI, 0.91–3.67).
All placentas studied were positive for at
least one chemical (mean residue number
7.6 ± 3.9). Detectable concentrations of
p,p´-DDE were found in 84.8% of placenta
samples, with a mean value of 9.21 ng/g of
placenta. Lindane and endosulfan-α, and
ether followed DDE in frequency of presence
and were detected in 61.4, 52.4, and 53.1%,
respectively, although at lower concentrations
(Table 2). A higher number of pesticides were
detected in cases than in controls (9.3 ± 3.2
vs. 6.9 ± 3.1, respectively; p = 0.002), but
there were no statistically significant differ-
ences between cases and controls in the mean
concentration of any pesticide except for
dieldrin (1.19 vs. 0.33 ng/g placenta, p <
0.05) and lindane (0.72 vs. 0.36 ng/g pla-
centa, p = 0.007). Residues of o,p´-DDT,
p,p´-DDT, lindane, endosulfan-α, and mirex
were more frequently detected in cases than
in controls, and the unconditional regression
analysis associated malformation risk with the
presence of these same chemicals, as follows:
o,p´-DDT (OR = 2.25; 95% CI, 1.03–4.89);
p,p´-DDT (OR = 2.63; 95% CI, 1.21–5.72),
lindane (OR = 3.38; 95% CI, 1.36–8.38),
mirex (OR = 2.85; 95% CI, 1.22–6.66), and
endosulfan-α (OR = 2.19; 95% CI,
0.99–4.82). Table 3 lists these findings and
results of the conditional regression analysis
with crude and adjusted ORs for malforma-
tions in relation to the presence of these ﬁve
selected pesticide residues.
Seventy-two percent of placentas from
cases and 54% of those from controls were
positive for estrogenicity of the α fraction.
Mean values of estrogenicity, measured as the
TEXB of the α fraction, were 2.92 Eeq pM/g
of placenta for cases versus 1.45 Eeq pM/g of
placenta for controls. In the unconditional
regression analysis, the TEXB of the α fraction
was borderline associated with the risk of mal-
formation, with an OR of 2.02 (95% CI,
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Table 2. Concentrations of organochlorine pesticides (ng/g of lipid) in placenta samples of cases and controls.
Cases (n = 48) Controls (n = 114)
No. Mean ± SD 25th 50th 75th Range No. Mean ± SD 25th 50th 75th Range
o,p′-DDD 19 28.7 ± 43.7 1.0 14.1 52.4 1.0–169.6 44 64.9 ± 158.3 1.0 11.6 62.4 1.0–997.0
p,p′-DDE 31 10.8 ± 28.0 2.6 4.0 8.9 0.5–158.1 92 8.7 ± 16.0 1.8 3.5 7.7 0.5–97.7
o,p′-DDT 23 3.6 ± 8.3 1.0 1.1 1.9 1.0–38.3 48 5.8 ± 10.7 1.0 1.5 4.8 1.0–40.5
p,p′-DDT 18 2.0 ± 5.2 1.0 1.0 1.0 1.0–22.2 30 9.1 ± 25.1 1.0 1.0 2.7 1.0–127.0
ΣDDTs 35 28.7 ± 47.3 4.4 10.2 29.6 1.0–206.9 104 39.9 ± 110.2 2.9 8.0 34.9 1.0–1025.1
E ether 20 0.2 ± 0.2 0.1 0.2 0.4 0.1–1.01 57 0.3 ± 0.3 0.1 0.2 0.4 0.1–1.0
E lactone 15 19.7 ± 15.6 1.2 21.5 28.4 0.1–55.3 33 23.7 ± 22.1 1.0 19.2 34.1 0.1–74.7
E diol 16 5.3 ± 4.4 1.5 4.1 8.8 0.5–13.8 55 8.1 ± 9.8 2.5 4.2 10.7 0.5–45.6
E sulf 26 5.6 ± 7.0 1.0 2.2 6.5 0.5–21.9 80 3.6 ± 6.0 1.2 2.0 3.5 0.5–44.6
E I 24 3.4 ± 6.1 0.5 0.5 4.9 0.5–28.3 52 4.9 ± 6.6 0.5 2.4 6.15 0.5–26.7
E II 22 4.1 ± 10.4 2.0 2.0 2.0 2.0–46.2 49 2.5 ± 2.7 2.0 2.0 2.2 2.0–10.7
ΣE 36 20.8 ± 25.0 2.7 8.0 36.3 0.14–103 103 19.7 ± 29.7 3.0 7.0 26.4 0.5–189.5
Aldrin 18 0.63 ± 0.2 1.0 1.0 1.2 1.0–1.0 39 1.9 ± 7.14 1.0 1.0 1.1 1.0–45.2
Dieldrin 11 3.8 ± 4.2 1.0 2.2 4.8 1.0–12.5 19 1.9 ± 2.5 1.0 1.0 1.8 1.0–9.6
Endrin 22 5.0 ± 4.8 3.0 3.8 6.5 3.0–19.7 48 7.4 ± 11.9 2.2 3.5 7.2 3.0–67.0
Lindane 29 0.9 ± 0.8 0.5 0.7 1.0 0.5–3.2 60 0.7 ± 1.0 0.2 0.3 1.0 0.5–6.87
M-chlor 19 1.2 ± 1.1 1.0 1.0 1.7 1.0–4.7 39 2.3 ± 6.2 1.0 1.2 1.4 1.0–34.5
Mirex 13 1.4 ± 1.1 0.1 0.1 2.5 1.0–3.0 18 3.7 ± 3.7 1.0 2.8 4.5 1.0–15.1
Chlordane 4 276 ± 355 41 139.8 511.5 3.0–791.9 11 138.4 ± 112.3 63 92.2 165.9 3.0–383.9
HCB 22 6.9 ± 11.6 1 2.7 4.3 0.5–41.6 55 9.49 ± 12.7 2.0 4.2 10.6 0.5–60.5
Abbreviations: E, endosulfan; HBC, hexachlorobenzene; M-chlor, methoxychlor. 25th, 50th, and 75th are percentiles. 0.84–4.80) that increased to an OR of 2.82
(95% CI, 1.10–7.24) in the conditional
regression analysis adjusted for maternal age
and birth weight (Table 3). The TEXB of the
β fractions was more frequently positive and
higher in cases versus controls but without
reaching statistical significance. Neither the
TEXB-α nor -β fraction showed association
with any of the 16 pesticides quantiﬁed. The
relationship between the estrogenicity of α
fractions (TEXB-α) and the variables most
frequently related to malformations was inves-
tigated. The variables associated with TEXB-α
levels were maternal age, educational level,
BMI before pregnancy, and parent occupa-
tion. All placentas from mothers working in
agriculture were positive (≥ LOD). 
When variables were simultaneously exam-
ined in a multivariate regression model, the
main predictors of urogenital malformations
were pregnancy weight gain, dieldrin levels,
and presence of mirex or lindane (Table 4). 
Discussion
We used a novel method to measure exposure
of the embryo-fetus to xenoestrogens by esti-
mating the estrogenicity resulting from the
combined effect of chemicals extracted from
placentas (TEXB measurement) (Fernandez
et al. 2004; Ibarluzea et al. 2004). Three of
four placentas from boys with cryptorchidism
and/or hypospadias and one of two placentas
from control boys had a measurable level of
estrogenicity due to xenoestrogens (TEXB of
the α fraction). We detected a statistically sig-
niﬁcant relationship between the risk of mal-
formation and xenoestrogen exposure in the
study population. Therefore, we are able to
report the ﬁrst demonstration of a signiﬁcant
relationship between male urogenital malfor-
mation and the estrogenicity of the α-frac-
tion—the estrogenicity due to bioaccumulated
organohalogenated xenoestrogens. Compared
with controls, cases had an OR for detectable
versus nondetectable TEXB-α of 2.82 (95%
CI, 1.10–7.24). 
These results support the environmental
working hypothesis for male sexual differentia-
tion in humans. This process is known to
depend on a balanced steroid ratio and is
therefore highly sensitive to disruption by
exogenous estrogens; exposure to EDCs would
provoke an unbalanced androgen/estrogen
ratio, leading to an inadequate maturation of
Sertoli and Leydig cells (de Kretser 2003;
Skakkebaek et al. 2001). Disagreements in the
scientiﬁc community about adverse trends in
male reproductive health may be partly related
to difficulties in comparing studies across
time, to the selection of study populations,
and to differences in clinical definitions and
diagnostic procedures for these diseases.
Moreover, epidemiologists traditionally ana-
lyze the incidence and risk factors separately
for each disorder. Skakkebaek and co-work-
ers (2001) proposed that sperm counts,
demand for assisted reproduction, testicular
cancer, hypospadias, and undescended testes
are all symptoms of a single underlying
entity, the so-called testicular dysgenesis syn-
drome. They concluded that environment
and lifestyle factors are among the most likely
causes, with minor participation of the
genomic background. 
Following proposals of separate genetic
but common environmental components of
risk for cryptorchidism and hypospadias (Akre
et al. 1999; Weidner et al. 1999), cryp-
torchidism and hypospadias were considered
comparable entities in terms of their etiology,
grouping together boys with one or both mal-
formations in the statistical analysis. The
prevalence of cryptorchidism and/or hypospa-
dias was 1.8% in our series, within the range
reported by studies in other geographic areas
(Boisen et al. 2004, 2005; Paulozzi 1999;
Preiksa et al. 2005; Toppari et al. 2001).
When the two malformations were considered
separately, the prevalence of cryptorchidism at
1 month of age was 1.1%, and the prevalence
of hypospadias at delivery was 0.74%. The
cohort study conducted by Preiksa et al.
(2005) detected a lower frequency of cryp-
torchidism at birth in Lithuanian boys (5.7%)
in comparison with Danes (9.0%) and a
higher frequency in comparison with Finns
(2.4%). Highly variable prevalences of cryp-
torchidism have been reported in Western
countries on the basis of registry studies
(Boisen et al. 2004; Paulozzi 1999; Toppari
et al. 2001). However, comparisons in the
incidence rate of urogenital malformations
among countries may be limited by differences
in study populations (registry versus cohort
studies), case definitions, and examination
techniques. The Spanish Collaborative Study
of Congenital Malformations (ECEMC)
reported (Martínez-Frias et al. 2004) that the
frequency of hypospadias in Spain was 1 of
284 male births (0.35%) and had remained at
this level for the past few decades until after
1996, when a decreasing frequency of severe
forms was recorded. The authors suggested
that this effect was probably caused by a radi-
cal change in exposure that affected the whole
country. Surprisingly, this change was not
observed in the prevalence of any other
congenital malformations.
All placentas had measurable concentra-
tions of at least one of the 16 organochlorine
pesticides quantified, reflecting the ubiquity
of exposure in the population, although the
number of quantifiable residues was signifi-
cantly higher in cases than in controls. No
single chemical could be positively and
significantly associated with the biologic
Fernandez et al.
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Table 4. Predictors of urogenital malformations in
multivariate analysis.
Variables Beta p-Value OR
Lindane
< LOD 1
≥ LOD 1.011 0.046 2.748
Dieldrin 0.179 0.079 1.196
Mirex 1.176 0.016
< LOD 1
≥ LOD 3.243
Pregnancy weight gain (kg) –0.096 0.027 0.908
Constant –0.896 0.178 0.408
All variables were simultaneously entered into the model
for prediction of urogenital malformations.
Table 3. Crude and adjusted ORs (95% CIs) for urogenital malformations among male offspring in relation
to the presence in placenta samples of specific endocrine disruptors and the TEXB, according to the
case/control status of newborn.
Cases Controls 
Variable [n (%)] [n (%)] p-Value COR (95% CI) AORa (95% CI)
o,p´-DDT
< LOD 12 (16.7) 60 (83.3) 0.047 1 1
≥ LOD 23 (33.3) 46 (66.7) 2.25 (1.03–4.89) 2.17 (0.96–5.00)
p,p´-DDT
< LOD 17 (18.1) 77 (81.9)  0.017 1 1
≥ LOD 18 (38.3) 29 (61.7) 2.63 (1.21–5.72) 2.17 (0.95–5.00)
Endosulfan I
< LOD 11 (16.4) 56 (83.6) 0.025 1 1
≥ LOD 24 (32.4) 50 (67.6) 2.19 (0.99–4.82) 2.49 (0.99–6.24)
Lindane
< LOD 6 (11.1)  48 (88.9) 0.002 1 1
≥ LOD 29 (33.3) 58 (66.7) 3.38 (1.36–8.38) 9.48 (2.43–36.96)
Mirex
< LOD 23 (20.7)  88 (79.3)  0.023 1 1
≥ LOD 12 (40.0) 18 (60.0) 2.85 (1.22–6.66) 3.42 (1.19–9.77)
TEXB-α fraction
< LOD 10 (18.2)  45 (81.8) 0.031 1 1
≥ LOD 25 (30.9) 56 (69.1) 2.02 (0.84–4.80) 2.82 (1.10–7.24)
TEXB-β fraction
< LOD 11 (19.6)  45 (80.4)  0.069 1 1
≥ LOD 24 (30.0) 56 (70.0) 1.75 (0.75–1.00) 2.31 (0.94–5.70)
Results were obtained from conditional logistic regression models. 
aAdjusted for mother’s age at delivery and infant weight at birth. effect measured by TEXB-α. There may be
several reasons for this lack of concordance.
Thus, the estrogenic effect measured in the
E-SCREEN bioassay is a consequence of the
combined effect of measured organohalogens;
and the estrogenic effect may be caused by
other chemicals not quantified, either other
organochlorine pesticides or other lipophilic
compounds.
Over the past three decades, published
research into the presence of organochlorine
pesticides in placenta tissue has been limited.
The highest concentrations detected in placen-
tas in our study were those of DDT, isomers,
and metabolites, followed by endosulfans,
with p,p´-DDE showing both highest mean
concentration and frequency. These ﬁndings
are far below the mean values reported in pla-
centa tissue of women in a neighboring region
of southeast Spain (Falcon et al. 2004). In the
latter series, recruited from 1998 to 2000, the
mean total DDT value found was similar to
ﬁndings in placenta in a Romanian population
in 1996–1997 (Hura et al. 1999). The present
p,p´-DDE results are similar to those recently
reported in placentas collected from 1997 to
2001 in Finland (Shen et al. 2005). In our
view, caution must be taken in comparing
concentrations of lipophilic endocrine disrup-
tor chemicals in adipose tissue with data
derived from lipid-adjusted concentrations in
blood/serum or placenta.
Nevertheless, our results showed an excess
risk of malformation associated with the pres-
ence of ﬁve pesticides (o,p´-DDT, p,p´-DDT,
endosulfan-α, lindane, and mirex). The ORs
were higher than unity, reaching 9.48 (95%
CI, 2.43–36.96) for lindane in the conditional
regression analysis adjusted for maternal age
and birth weight. In the multivariate regres-
sion model, presence of mirex or lindane was a
predictor of urogenital malformations. 
A significant association was observed
between maternal involvement in agriculture
activities and an increased frequency of con-
genital malformations in the offspring,
although agricultural employment by fathers
was not associated with a signiﬁcant increase
in risk. Other authors have reported a higher
risk of congenital anomalies at birth according
to occupation (Dolk et al. 1998; Garcia et al.
1999; Hosie et al. 2000; Irgens et al. 2000;
Kristensen et al. 1997; Pierik et al. 2004;
Vrijheid et al. 2003; Weidner et al. 1998). In
fact, pesticide exposure is likely in agricultural
work even when direct handling of chemicals
is not reported (Garcia et al. 1999). Thus,
entry into a greenhouse after spraying can be a
major source of exposure, as can be the use of
fertilizers and crop-preserving chemicals.
Moreover, factors related to residence in an
agricultural setting may be an important
source of inadvertent exposure to pesticides
(Olea et al. 1999). 
No effect of parental age on urogenital
malformations was observed, in agreement
with most (Preiksa et al. 2005; Weidner et al.
1999) but not all (Fisch et al. 2001) of the
previous studies. An increased risk of these
malformations was, however, significantly
associated with lower birth weight, as previ-
ously documented (Berkowitz et al. 2003;
Weidner et al. 1999), and also appeared to be
related to low gestational age although signiﬁ-
cance was not reached, unlike in some other
reports (Berkowitz et al. 2004; Preiksa et al.
2005). In our region, Lopez-Espinosa et al.
(2006) found that a higher number of
organochlorine pesticide residues in placenta
was associated with lower birth weight, con-
ﬁrming these observations. 
A 4-fold increased risk of malformation in
the sons of women with a history of stillbirth
was noted (OR = 4.2; 95% CI, 1.11–16.66),
confirming previous observations (Weidner
et al. 1999). Although cryptorchidism and
hypospadias have frequently been described in
associated congenital malformations (Mayr
et al. 1999), only minor concomitant diseases
of the urogenital tract were observed in our
series, confirming findings by other authors
(Biggs et al. 2002; Preiksa et al. 2005).
Other variables had less or no influence
on the risk in our study population. An
increase in malformation has been associated
with cesarean delivery (Aschim et al. 2004;
Rueda-Domingo et al. 2001), but no signiﬁ-
cant association was observed in the present
study (OR = 2.44; 95% CI, 0.51–11.62). 
Seasonal cyclicity in the month of deliv-
ery/conception in relation to these malforma-
tions has been reported. In agreement with
some of these authors (e.g., Mayr et al. 1999),
a seasonal cyclicity was also observed in the
present study, with a peak of cases born
between January and March (COR = 1.28;
95%CI, 1.19–9.12). If the first trimester is
considered the most vulnerable time for the
embryo-fetus, and if spring is the season dur-
ing which most of the pesticides were applied,
this additional information may strengthen
the results. Unfortunately, we do not have
accurate data on the application of pesticides
in spring versus other seasons. 
Finally, maternal weight before pregnancy,
categorized below and above the median value
of the BMI (23 kg/m2), showed close to a sig-
niﬁcant association. We have no explanation
for this ﬁnding, but it would be interesting to
consider it together with the observation of a
lower body weight increase during pregnancy
in mothers of cases versus mothers of control
boys (11.3 ± 4.7 kg vs. 13.9 ± 5.5 kg).
In conclusion, although the complexity of
human biology makes it very difficult to
establish a relationship between EDC expo-
sure and male congenital malformations, our
data suggest that environmental chemicals
with estrogenic activity play a role in the risk
of cryptorchidism and/or hypospadias.
Unfortunately, few comparable studies have
addressed this issue (e.g., Vidaeff and Sever
2005), and these were limited to a small num-
ber of EDCs (Hosie et al. 2000; Longnecker
et al. 2002; Vrijheid et al. 2003). However,
the present study illustrates the utility for
exposure assessment of a biomarker that eval-
uates the combined effects of bioaccumulated
xenoestrogens in placentas. 
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